Downregulation of histone deacetylase 8 (HDAC8) alleviated the progression of oral submucous fibrosis

被引:4
|
作者
Yang, Hui-Wen [1 ,2 ]
Sun, Yi-Hwa [3 ]
Fang, Chih-Yuan [3 ,4 ]
Ohiro, Yoichi [5 ]
Liao, Heng-Yi [1 ]
Liao, Yi-Wen [6 ,7 ]
Kao, Yu-Hsun [8 ,9 ]
Yu, Cheng-Chia [1 ,2 ,7 ]
机构
[1] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan
[2] Chung Shan Med Univ Hosp, Dept Dent, Taichung, Taiwan
[3] Taipei Med Univ, Wan Fang Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan
[4] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei, Taiwan
[5] Hokkaido Univ, Fac Dent Med, Grad Sch Dent Med, Div Oral Pathobiol Sci, Sapporo, Japan
[6] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
[7] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan
[8] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan
[9] Taipei Med Univ, Wan Fang Hosp, Dept Med Educ & Res, Taipei, Taiwan
关键词
Oral submucous fibrosis; HDAC8; BUCCAL MUCOSAL FIBROBLASTS; MYOFIBROBLAST TRANSDIFFERENTIATION; INHIBITION; QUID; LEUKOPLAKIA; CANCER;
D O I
10.1016/j.jds.2022.10.007
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/purpose: Oral submucous fibrosis (OSF) is a premalignant disorder that is associ-ated with betel nut chewing. The purpose of the study was to establish the role of histone dea-cetylase (HDAC) 8, one of histone deacetylases, in the regulation of fibrotic conditions to provide a therapeutic potential for OSF. Materials and methods: First, we examined the expression of HDAC8 in fibrotic buccal mucosal fibroblasts (fBMFs) and OSF tissues. Markers of myofibroblasts and TGF-b signaling were con-ducted in fBMFs with HDAC8 knockdown were examined. Furthermore, epithelial-mesenchymal transition (EMT) markers, collagen gel contraction and migration ability were also examined in fBMFs transfected with sh-HDAC8. HDAC8 inhibitor was used to analyze the collagen gel contraction and wound healing ability in fBMFs. Results: We observed the mRNA expression of HDAC8 was significantly increased in fBMFs. Compared to normal tissues, the protein level of HDAC8 was upregulated in OSF. Next, mRNA and protein expression of HDAC8 was significantly decreased, accompanying downregulation of a-SMA and COL1A1 in fBMFs infected with sh-HDAC8. To determine the critical role of HDAC8 in OSF fibrogenesis, results revealed that TGF-I3 secretion and the expression of EMT transcription factor SNAIL and p-Smad were significantly decreased in HDAC8-knockdown fBMFs. We further demonstrated that collagen gel contraction and migration ability were significantly decreased in fBMFs transfected with sh-HDAC8. Last, results revealed that significantly reduced collagen gel contraction and wound healing ability in fBMFs with HDAC8 inhibitor treatment. Conclusion: We concluded that downregulation of HDAC8 alleviated the activities of myofibro-blasts and TGF-I3/Smad signaling pathway in OSF.(c) 2022 Association for Dental Sciences of the Republic of China. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:652 / 658
页数:7
相关论文
共 50 条
  • [1] A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present)
    Banerjee, Suvankar
    Ghosh, Balaram
    Jha, Tarun
    Adhikari, Nilanjan
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2024, 34 (10) : 1019 - 1045
  • [2] Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
    Banerjee, Suvankar
    Adhikari, Nilanjan
    Amin, Sk Abdul
    Jha, Tarun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 164 : 214 - 240
  • [3] A detail survey and analysis of selectivity criteria for indole-based histone deacetylase 8 (HDAC8) inhibitors
    Moinul, Md.
    Amin, Sk. Abdul
    Khatun, Samima
    Das, Sanjib
    Jha, Tarun
    Gayen, Shovanlal
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1271
  • [4] Methionine 274 Is Not the Determining Factor for Selective Inhibition of Histone Deacetylase 8 (HDAC8) by L-Shaped Inhibitors
    Jansch, Niklas
    Lang, Kim Leoni
    Meyer-Almes, Franz-Josef
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [5] Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)?
    Amin, Sk Abdul
    Khatun, Samima
    Gayen, Shovanlal
    Das, Sanjib
    Jha, Tarun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258
  • [6] Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8
    Stoddard, Shana V.
    May, Xavier A.
    Rivas, Fatima
    Dodson, Kyra
    Vijayan, Sajith
    Adhika, Swetha
    Parker, Kordarius
    Watkins, Davita L.
    MOLECULAR INFORMATICS, 2019, 38 (03)
  • [7] The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity
    Negmeldin, Ahmed T.
    Knoff, Joseph R.
    Pflum, Mary Kay H.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 143 : 1790 - 1806
  • [8] Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis
    Zhang, Yunhe
    Zou, Jianan
    Tolbert, Evelyn
    Zhao, Ting C.
    Bayliss, George
    Zhuang, Shougang
    FASEB JOURNAL, 2020, 34 (06) : 7295 - 7310
  • [9] Inhibition and Mechanism of HDAC8 Revisited
    Chen, Kai
    Zhang, Xiaoxiao
    Wu, Yun-Dong
    Wiest, Olaf
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (33) : 11636 - 11643
  • [10] Development of a Potent and Selective HDAC8 Inhibitor
    Ingham, Oscar J.
    Paranal, Ronald M.
    Smith, William B.
    Escobar, Randolph A.
    Yueh, Han
    Snyder, Tracy
    Porco, John A., Jr.
    Bradner, James E.
    Beeler, Aaron B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 929 - 932